Carter's Toekomstige groei
Future criteriumcontroles 1/6
De winst van Carter's zal naar verwachting dalen met 6.1% per jaar, terwijl de jaarlijkse omzet naar verwachting zal groeien met 0.3% per jaar. De winst per aandeel zal naar verwachting dalen met 4.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 20.6% zijn.
Belangrijke informatie
-6.1%
Groei van de winst
-4.6%
Groei van de winst per aandeel
Luxury winstgroei | 13.7% |
Inkomstengroei | 0.3% |
Toekomstig rendement op eigen vermogen | 20.6% |
Dekking van analisten | Low |
Laatst bijgewerkt | 12 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Return Trends At Carter's (NYSE:CRI) Aren't Appealing
Oct 30Carter's Q3 Disappointed And The Stock Is At A Decade Low, But Only Fairly Valued
Oct 28Is Carter's (NYSE:CRI) A Risky Investment?
Sep 21Earnings Working Against Carter's, Inc.'s (NYSE:CRI) Share Price
Sep 03Is Now An Opportune Moment To Examine Carter's, Inc. (NYSE:CRI)?
Aug 20Carter's, Inc. Just Recorded A 61% EPS Beat: Here's What Analysts Are Forecasting Next
Jul 31Carter's: In Fairly Valued Territory, But There Will Be Better Opportunities Later
Jul 31Carter's: An Investment That Is Appealing To More Than Just Parents
Jun 17Carter's, Inc.'s (NYSE:CRI) Business And Shares Still Trailing The Market
May 22Carter's Excellent Business Is A Buy At P/B Ratios Below 3
May 02Is It Time To Consider Buying Carter's, Inc. (NYSE:CRI)?
Apr 24Carter's: With A 4.4% Yield, Pullback To Key Support Is A Buying Opportunity
Apr 15Be Wary Of Carter's (NYSE:CRI) And Its Returns On Capital
Apr 05Carter's (NYSE:CRI) Will Pay A Larger Dividend Than Last Year At $0.80
Mar 01Carter's: Taking A More Cautious Approach
Feb 13Pinning Down Carter's, Inc.'s (NYSE:CRI) P/E Is Difficult Right Now
Feb 09Is There Now An Opportunity In Carter's, Inc. (NYSE:CRI)?
Jan 24Carter's (NYSE:CRI) Has Some Way To Go To Become A Multi-Bagger
Jan 04Carter's (NYSE:CRI) Has Affirmed Its Dividend Of $0.75
Nov 24Carter's: Growth Concerns Despite FCF Strength
Nov 16These 4 Measures Indicate That Carter's (NYSE:CRI) Is Using Debt Extensively
Nov 03What Does Carter's, Inc.'s (NYSE:CRI) Share Price Indicate?
Oct 19Carter's, Inc. (NYSE:CRI) Shares Could Be 34% Above Their Intrinsic Value Estimate
Oct 04Investors Could Be Concerned With Carter's' (NYSE:CRI) Returns On Capital
Sep 17Carter's (NYSE:CRI) Will Pay A Dividend Of $0.75
Aug 28Carter's: A Dominant Player With Limited Upside
Jul 20What Does Carter's, Inc.'s (NYSE:CRI) Share Price Indicate?
Jul 10Is Carter's (NYSE:CRI) Using Too Much Debt?
Jun 23Carter's' (NYSE:CRI) Returns Have Hit A Wall
Jun 08Carter's' (NYSE:CRI) Dividend Will Be $0.75
May 23Are Carter's, Inc. (NYSE:CRI) Investors Paying Above The Intrinsic Value?
May 05Is It Too Late To Consider Buying Carter's, Inc. (NYSE:CRI)?
Apr 01Is Carter's (NYSE:CRI) A Risky Investment?
Mar 12Carter's (NYSE:CRI) Is Due To Pay A Dividend Of $0.75
Feb 27Carter's Q4 2022 Earnings Preview
Feb 23Carter's (NYSE:CRI) Has Some Way To Go To Become A Multi-Bagger
Feb 22Carter's Still Offers Upside, But A Watchful Eye Is Advised
Jan 24Carter's, Inc. (NYSE:CRI) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 23Is It Too Late To Consider Buying Carter's, Inc. (NYSE:CRI)?
Dec 27Carter's (NYSE:CRI) Takes On Some Risk With Its Use Of Debt
Nov 30Here's What To Make Of Carter's' (NYSE:CRI) Decelerating Rates Of Return
Nov 14Carter's: Continued Pressure On Revenue Growth And Margins
Nov 03Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 2,862 | 194 | N/A | N/A | 3 |
12/31/2025 | 2,803 | 175 | 169 | N/A | 4 |
12/31/2024 | 2,819 | 187 | 141 | N/A | 4 |
9/28/2024 | 2,842 | 226 | 278 | 335 | N/A |
6/29/2024 | 2,875 | 234 | 354 | 412 | N/A |
3/30/2024 | 2,911 | 230 | 403 | 461 | N/A |
12/30/2023 | 2,946 | 228 | 469 | 529 | N/A |
9/30/2023 | 3,000 | 203 | 456 | 512 | N/A |
7/1/2023 | 3,027 | 202 | 341 | 391 | N/A |
4/1/2023 | 3,127 | 215 | 248 | 294 | N/A |
12/31/2022 | 3,213 | 246 | 48 | 88 | N/A |
10/1/2022 | 3,363 | 263 | 8 | 43 | N/A |
7/2/2022 | 3,435 | 283 | 92 | 125 | N/A |
4/2/2022 | 3,480 | 317 | 111 | 144 | N/A |
1/1/2022 | 3,486 | 336 | 231 | 268 | N/A |
10/2/2021 | 3,414 | 338 | 241 | 277 | N/A |
7/3/2021 | 3,389 | 335 | 364 | 401 | N/A |
4/3/2021 | 3,157 | 273 | 527 | 563 | N/A |
1/2/2021 | 3,024 | 109 | 556 | 588 | N/A |
9/26/2020 | 3,135 | 135 | 592 | 633 | N/A |
6/27/2020 | 3,213 | 113 | 467 | 520 | N/A |
3/28/2020 | 3,433 | 148 | 276 | 336 | N/A |
12/28/2019 | 3,519 | 261 | 326 | 387 | N/A |
9/28/2019 | 3,505 | 267 | 346 | 408 | N/A |
6/29/2019 | 3,486 | 279 | 301 | 358 | N/A |
3/30/2019 | 3,448 | 272 | 271 | 329 | N/A |
12/29/2018 | 3,462 | 280 | 292 | 356 | N/A |
9/29/2018 | 3,404 | 285 | 168 | 233 | N/A |
6/30/2018 | 3,428 | 296 | N/A | 325 | N/A |
3/31/2018 | 3,423 | 296 | N/A | 310 | N/A |
12/30/2017 | 3,401 | 300 | N/A | 330 | N/A |
9/30/2017 | 3,307 | 252 | N/A | 370 | N/A |
7/1/2017 | 3,260 | 250 | N/A | 391 | N/A |
4/1/2017 | 3,208 | 249 | N/A | 325 | N/A |
12/31/2016 | 3,199 | 256 | N/A | 369 | N/A |
10/1/2016 | 3,132 | 242 | N/A | 279 | N/A |
7/2/2016 | 3,080 | 240 | N/A | 366 | N/A |
4/2/2016 | 3,053 | 240 | N/A | 349 | N/A |
1/2/2016 | 3,014 | 236 | N/A | 308 | N/A |
10/3/2015 | 3,017 | 231 | N/A | 404 | N/A |
7/4/2015 | 2,966 | 218 | N/A | 276 | N/A |
4/4/2015 | 2,927 | 207 | N/A | 339 | N/A |
1/3/2015 | 2,894 | 192 | N/A | 282 | N/A |
9/27/2014 | 2,794 | 167 | N/A | 171 | N/A |
6/28/2014 | 2,756 | 157 | N/A | 173 | N/A |
3/29/2014 | 2,699 | 151 | N/A | 187 | N/A |
12/28/2013 | 2,639 | 158 | N/A | 210 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De winst van CRI zal naar verwachting de komende 3 jaar dalen ( -6.1% per jaar).
Winst versus markt: De winst van CRI zal naar verwachting de komende 3 jaar dalen ( -6.1% per jaar).
Hoge groeiwinsten: De winst van CRI zal naar verwachting de komende 3 jaar dalen.
Omzet versus markt: De omzet van CRI ( 0.3% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 9% per jaar).
Hoge groei-inkomsten: De omzet van CRI ( 0.3% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen CRI zal naar verwachting over 3 jaar hoog zijn ( 20.6 %)